Efficacy of triple combination therapy with zidovudine (ZDV) plus zalcitabine (ddC) plus lamivudine (3TC) versus double (ZDV+3TC) combination therapy in patients previously treated with ZDV+ddC — Lı́dia Ruiz (1996) | RDL Network
Efficacy of triple combination therapy with zidovudine (ZDV) plus zalcitabine (ddC) plus lamivudine (3TC) versus double (ZDV+3TC) combination therapy in patients previously treated with ZDV+ddC
Article 1996 en
Authors
LR
Lı́dia Ruiz
JR
Joan Romeu
JM
Javier Martínez‐Picado
Abstract
1 min read
Both therapy strategies, switching ddC to 3TC or adding 3TC, significantly improved the virological and immunological efficacy compared with continuing ZDV/ddC. Our results support the use of 3TC in patients previously treated with the ZDV/ddC combination.
María‐Victoria Mateos, Maria Gavriatopoulou, Thierry Façon, Holger W. Auner, Xavier Leleu, Roman Hájek, Meletios A Dimopoulos, Sosana Delimpasi, Maryana Simonova, Ivan Špıčka, Luděk Pour, Iryna Kriachok, Halyna Pylypenko, Vadim Doronin, Ganna Usenko, Reuben Benjamin, Tuphan Kanti Dolai, Dinesh Kumar Sinha, Christopher P. Venner, Mamta Garg, Don A. Stevens, Hang Quach, Sundar Jagannath, Philippe Moreau, Moshe Levy, Ashraf Badros, Larry D. Anderson, Nizar J. Bahlis, Michèle Cavo, Yi Chai, Jacqueline Jeha, Melina Arazy, Jatin J. Shah,
Inge Marie Svane, Santosh Nair, Igor Puzanov, Caroline Robert, Jessica C. Hassel, Shahneen Sandhu, Anita Vedel Christiansen, Kath Lowery, Kristine Pemberton, Mohammad Al Hajj, Scott J. Diede, E. Ehrnrooth, Alexander M.M. Eggermont
Lauren Brown, Alison M. Weppler, Prachi Bhave, Clara Allayous, James R. Patrinely, Patrick A. Ott, Shahneen Sandhu, Andrew Haydon, Célèste Lebbé, Douglas B. Johnson, Georgina V. Long, Alexander Menzies, Matteo S. Carlino
Discussion(0)
No comments yet. Be the first to comment.